ALB and nutritional deficiency disease: For clinical implementation, we recommend: (1) systematic mCONUT screening at admission to stratify high-risk patients; (2) dynamic monitoring of albumin (>3.8 g/dl) and lymphocyte count (>1.8 × 103/μl); and (3) post-discharge nutritional protocols to mitigate the inflammation-malnutrition cycle.